New Issue: Integrated Pharmaceuticals closes $1.05 million sale of units

By Sheri Kasprzak

New York, Dec. 21 - Integrated Pharmaceuticals, Inc. sealed a private placement of units for $1,050,260.

The company sold 17,504,334 units at $0.06 each to a group of investors that included directors David Smith and Sally Johnson-Chin.

The units comprise one share and one half-share warrant. Each whole warrant is exercisable at $0.35 through June 30, 2008.

Based in Fitchburg, Mass., Integrated develops small molecules and recombinant DNA technology-derived products used in the pharmaceutical, nutraceutical and functional food industries.

Issuer:	Integrated Pharmaceuticals, Inc.
Issue:	Units of one share and one half-share warrant
Amount:	$1,050,260
Units:	17,504,334
Price:	$0.06
Warrants:	One half-share warrant per unit
Warrant expiration:	June 30, 2008
Warrant strike price:	$0.35
Investors:	David Smith, Sally Johnson-Chin, others
Settlement date:	Dec. 21
Stock symbol:	OTCBB: INTP
Stock price:	$0.20 at close Dec. 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.